Rocky Mountain Cancer Centers — Boulder, Colorado

Rocky Mountain Cancer Centers is a clinical research site located in Boulder, Colorado, United States 80303.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers has participated in 26 clinical trials with 6 currently active.

Therapeutic areas: Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Sponsors: CTI BioPharma, Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers?

Rocky Mountain Cancer Centers has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers conducted?

Rocky Mountain Cancer Centers has 26 clinical trials on record, with 6 currently active. Their work covers Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Is Rocky Mountain Cancer Centers accredited by Crixeo Health?

Rocky Mountain Cancer Centers has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.